Who owns Wave Life Sciences Ltd. (WVE)? Elite investor 13F holders
3 tracked elite investors reported holding Wave Life Sciences Ltd as of 2026-09-30, including Maverick Capital, D.E. Shaw, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Maverick Capital | Wave Life Sciences Ltd | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Maverick Capital | Common Stock, $0.001 par value per share | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 35966083.00 USD | 9720563.000000 | Shares | buy | Original filing |
| D.E. Shaw | Wave Life Sciences Ltd | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Renaissance Technologies LLC | Wave Life Sciences Ltd | SHARE | 2026-09-30 | 2026-11-12 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| D.E. Shaw | Common Stock, $0.001 par value per share | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 9407087.00 USD | 2542456.000000 | Shares | buy | Original filing |
| Renaissance Technologies LLC | Common Stock, $0.001 par value per share | SHARE | 2026-09-30 | 2026-11-12 00:00:00 | 8091604.00 USD | 2186920.000000 | Shares | buy | Original filing |
| Duquesne Family Office | Wave Life Sciences Ltd | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.